Method for producing beta crystal system anhydrous aztreonam
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- BEIJING GUANGFENG XIANFENG BIOTECH
- Publication Date
- 2008-06-11
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1
Abstract
Description
technical field
[0001] The invention relates to a production method of anhydrous β crystal form aztreonam crystal. Background technique
[0002] Aztreonam (Aztreonam) shown in molecular formula I is a synthetic monocyclic β-lactam antibiotic, which has antibacterial activity against Gram-negative bacteria.
[0003]
[0004] Molecular formula I
[0005] Some references report the preparation technology of aztreonam, for example: US Patent Nos. 4,775,670 and 5,194,604. Aztreonam has polymorphism, and US Pat. No. 4,826,973 reports four different crystals of aztreonam, namely α-, β-, γ-, and δ-types. The α crystal form is a hydrous crystal, usually containing 7-15% water, and has poor stability. Therefore, it should be transformed into the β crystal form, which has the characteristics of anhydrous, non-hygroscopic, good fluidity, smaller surface area, and better stability, and is more suitable for pharmaceutical use.
[0006] U.S. Patent No. 4,946,838 reports the preparat...